Filing Details

Accession Number:
0001179110-16-028706
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-16 13:57:57
Reporting Period:
2016-08-15
Filing Date:
2016-08-16
Accepted Time:
2016-08-16 13:57:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1353496 Kevin Guest 3838 West Parkway Blvd
Salt Lake City UT 84120
Co-C.e.o. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-15 16,285 $57.62 16,285 No 4 M Direct
Common Stock Disposition 2016-08-15 16,285 $131.08 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2016-08-15 29,250 $0.00 29,250 $57.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,250 2016-08-15 2018-03-15 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II
  2. Weighted Average Price $131.0776. The Price range in multiple transactions was $130.50 to $131.98 inclusively.